Verified stock metrics
TransCode Therapeutics Key Stock Metrics
TransCode Therapeutics (RNAZ) market cap, valuation, profitability and growth m…
Direct answer
TransCode Therapeutics has 6 verified key metrics available.
Market capitalization, valuation, profitability and growth facts share the same observation time.
Only reported values are shown. Missing values are not estimated.
Market data checked August 21, 2026.
Get free TransCode Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Market capitalization
- $3.14M
- Price-to-book ratio
- 2.18x
- Return on equity
- -59.28%
- 52-week price range
- $2.87 to $20.99
- Profit margin
- 0%
- Debt-to-equity ratio
- 0.47%
Explore related company data
View TransCode Therapeutics's market capitalizationView TransCode Therapeutics's price-to-book ratioView TransCode Therapeutics's return on equityView TransCode Therapeutics's 52-week price rangeView TransCode Therapeutics's profit marginView TransCode Therapeutics's debt-to-equity ratioReturn to TransCode Therapeutics profile